JOHNSON & JOHNSON

CIK

200406

Location

NEW BRUNSWICK, NJ

Portfolio Value

Small $798,649,907

Diversification

Moderately concentrated

Reports for

Johnson & Johnson Innovation - JJDC, Inc.

Filing Date

Global Rank

#2,165 / 8,517 ▲ 170

Top Industry

Biotechnology 94.9%

3Y Alpha vs SPY

+23.5%

Period ended 49 days ago

Filed Aug 6, 2026 · 12d

20 quarters · since Sep 2021

Clone Performance

Aug 2023–Aug 2026 · vs SPY

Hypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.

Cloned portfolio

+200.6%

SPY

+77.9%

Annualised alpha

+23.2%

Max drawdown

−47.7%

Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. Returns use comparable raw closes and exclude dividends; a captured split can shorten the simulated window. It tracks 100% of reported value on average across 13 quarters. Past performance does not predict future results.

Portfolio Concentration

15 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026

Top Position

37.6%

−2.0 pts

Top 5

88.7%

−0.7 pts

Top 10

98.4%

−0.6 pts

HHI

2,370

Moderately concentrated−115

Portfolio Trend

20 quarters · across all stocks

Sector Breakdown

As of Jun 30, 2026

Sector	% Portfolio	Value	Positions
Healthcare	98.5%	$786,807,401	14
Technology	1.5%	$11,842,506	1

Last Quarter's Activity

Export CSV

Jun 30, 2026 vs Mar 31, 2026

Added To

Positions the filer increased

No qualifying positions this quarter.

Trimmed

Positions the filer reduced

No qualifying positions this quarter.

New Positions

Positions the filer opened this quarter

1 positions

Ticker	Company	Shares	Value	Open
CBRS	Cerebras Systems Inc.	53,586	$11,842,506
No positions match the current search.

Sold Out

Positions the filer fully exited

2 positions

Ticker	Company	Shares	Value
RLYB	Rallybio Corp	152,901	$1,371,521
NNOX	Nano-X Imaging Ltd.	83,554	$189,667
No positions match the current search.

Portfolio Positions

Compact Export CSV View 13F filing

15 tracked positions · $798,649,907 total · filing declares 15 positions · $798,650,757 · as of Jun 30, 2026

All sectors Healthcare Technology

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	% of Portfolio
PTGX	Protagonist Therapeutics, Inc Healthcare	Held	2,449,183	0	$300,220,852	+16.3%	37.59%
NBTX	Nanobiotix S.A. Healthcare	Held	5,623,816	0	$212,017,863	+22.1%	26.55%
MGTX	MeiraGTx Holdings plc Healthcare	Held	6,641,064	0	$89,720,774	+56.0%	11.23%
RAPP	Rapport Therapeutics, Inc. Healthcare	Held	1,784,517	0	$74,360,823	+33.2%	9.31%
CTNM	Contineum Therapeutics, Inc. Healthcare	Held	1,979,173	0	$32,438,645	+25.5%	4.06%
LEGN	Legend Biotech Corp Healthcare	Held	814,586	0	$23,525,243	+59.6%	2.95%
CVRX	CVRx, Inc. Healthcare	Held	4,024,861	0	$20,687,785	−45.7%	2.59%
XNCR	Xencor Inc Healthcare	Held	748,062	0	$12,043,798	+33.5%	1.51%
CBRS	Cerebras Systems Inc. Technology	NEW	53,586	NEW	$11,842,506	NEW	1.48%
FATE	Fate Therapeutics Inc Healthcare	Held	3,379,064	0	$9,123,472	+125.0%	1.14%
PRCT	PROCEPT BioRobotics Corp Healthcare	Held	357,939	0	$8,082,262	−9.7%	1.01%
NMRA	Neumora Therapeutics, Inc. Healthcare	Held	1,849,445	0	$3,144,056	−12.8%	0.39%
VOR	Vor Biopharma Inc. Healthcare	Held	53,732	0	$989,206	+3.2%	0.12%
LAB	Standard Biotools Inc. Healthcare	Held	311,967	0	$255,812	−10.9%	0.03%
ACET	Adicet Bio, Inc. Healthcare	Held	22,779	0	$196,810	+26.9%	0.02%

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.